Skip to content

RAES BV

Active
Private limited companyfounded 2000active for 26 yearsLuikersteenweg 179, 3800 Sint-Truiden, BelgiumKBO/BCE: BE 0471.462.758
Summary

RAES BV has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €550,356 and a net result of €59,911. Equity is growing by about 6% per year across the filed financial years. Its solvency ranks better than 74% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741Manufacture of medical and dental instruments and supplies NACE 32500
1 site
Size
€902,009total assets 2025
Staff
1.4 FTE
Equity
€550,356
Profit
€59,911
Turnover not published (abbreviated format)
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
2025 accounts 2 days early3 deeds in the Belgian Official Gazette
Why 96lowers riskFounded in 2000Equity €550,356 (61.0% of total assets)Size: 1.4 FTE, total assets €902,009Liquidity: current ratio 2.37, cash €110,367Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 68% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 86-5
equity 61.0% of total assets
Liquidity 63-4
short-term debt 13.7% · cash 12.2%
Profitability 77+1
return on assets 6.6%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,222 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025highest value 08-2025: < 0.1%▼ -0.2 percentage points vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%▲ +0.1 percentage points vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €50,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.37, compared with 3.17 in 2024, above the usual 1.5; short-term debt: 13.7% and cash: 12.2% of total assets), and 39% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 74% on solvency, 70% on liquidity, 65% on profitability and 62% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Founded in 2000
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €550,356 (61.0% of total assets)
NBB · annual accounts
lowers risk · Size: 1.4 FTE, total assets €902,009
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 2.37, cash €110,367
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
2 days early
2024
on the day
2023
on the day
2022
5 days early
2021
5 days late
2020
10 days late
2019
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 5 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Equity above €500,000equity €550,356 ▲10.8%
  3. Annual accounts filedfinancial year 2024 · abbreviated…

Key points

  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View
  • Active since 2000founded 20-03-2000 26 years View
  • Total assets 20256 financial years filed €902,009 View

By topic

Financials

Financial year
2025
Total assets
€902,009
Profit
€59,911
Solvency
61.0%
Total assets▲ 19.4%
Net result
20182025
Go to Financials

Timeline

Events
31
Since
2001
Next accounts
by 31-07-2027
  1. 31-12-2024Back to profit
  2. 05-08-2024General meeting · Director resignation
  3. 31-07-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of medical and orthopaedic goods, excluding…NACE 47741
Founded
20-03-2000
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about RAES BV

What is the company number of RAES BV?
0471.462.758. In Belgium the VAT number is the company number with BE in front: BE 0471.462.758.
Where is RAES BV based?
The registered office is at Luikersteenweg 179, 3800 Sint-Truiden.Company details
What does RAES BV do?
According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
What is the legal form of RAES BV?
Private limited company (BV).
When was RAES BV founded?
On 20-03-2000.
Is RAES BV still active?
Yes, RAES BV is an active enterprise in the KBO register.
How many employees does RAES BV have?
On average 1.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of RAES BV?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is RAES BV profitable?
In financial year 2025, RAES BV made a profit of €59,911.
Where can I find the annual accounts of RAES BV?
RAES BV filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of RAES BV due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to RAES BV

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.